Literature DB >> 28359098

Attenuation of Resting but Not Load-Mediated Protein Synthesis in Prostate Cancer Patients on Androgen Deprivation.

Erik D Hanson1,2,3, André R Nelson1, Daniel W D West4, John A Violet5, Lannie O'Keefe2, Stuart M Phillips4, Alan Hayes1,2,6.   

Abstract

CONTEXT: Androgen deprivation therapy (ADT) is a common prostate cancer (PCa) treatment but results in muscular atrophy. Periodic increases in muscle protein synthesis (MPS) that occur after resistance exercise or protein intake may ameliorate this muscle loss, but the impact of these anabolic stimuli during ADT is unclear.
OBJECTIVE: To determine the acute MPS response to whey protein supplementation with and without resistance exercise during ADT.
DESIGN: Acute response in PCa patients vs age-matched controls (CON).
SETTING: Academic laboratory setting. PARTICIPANTS: PCa patients on ADT (N = 8) and CON (N = 10). INTERVENTION: A standardized diet was consumed for 2 days prior to performing unilateral knee extension resistance exercise followed by ingestion of 40 g of whey protein. MAIN OUTCOME MEASURES: Bilateral biopsies and stable isotope infusions were used to determine MPS rates at rest after protein ingestion with and without resistance exercise.
RESULTS: Baseline MPS during ADT was suppressed relative to CON (P = 0.01). Protein consumption stimulated MPS in both groups (approximate twofold increase, both P < 0.001), but to a greater extent in CON (P = 0.003). Protein plus resistance exercise increased MPS (∼3.4-fold increase, both P < 0.001) to a greater extent than did protein alone (P < 0.001), but with no difference between groups (P = 0.380).
CONCLUSIONS: ADT reduces basal and protein feeding-induced rises in MPS; however, combined protein ingestion with resistance exercise stimulated MPS to a similar degree as CON. Testosterone appears to play a role in maintaining muscle mass but is not necessary to initiate a robust response in MPS following resistance exercise when combined with protein ingestion.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28359098     DOI: 10.1210/jc.2016-3383

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Exercise-Based Interventions to Counteract Skeletal Muscle Mass Loss in People with Cancer: Can We Overcome the Odds?

Authors:  Kelcey A Bland; Imre W K Kouw; Luc J C van Loon; Eva M Zopf; Ciaran M Fairman
Journal:  Sports Med       Date:  2022-02-04       Impact factor: 11.136

Review 2.  Modulating Metabolism to Improve Cancer-Induced Muscle Wasting.

Authors:  Fabio Penna; Riccardo Ballarò; Marc Beltrá; Serena De Lucia; Paola Costelli
Journal:  Oxid Med Cell Longev       Date:  2018-01-29       Impact factor: 6.543

3.  A potent liver-mediated mechanism for loss of muscle mass during androgen deprivation therapy.

Authors:  Teresa Lam; Mark McLean; Amy Hayden; Anne Poljak; Birinder Cheema; Howard Gurney; Glenn Stone; Neha Bahl; Navneeta Reddy; Haleh Shahidipour; Vita Birzniece
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

Review 4.  Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage.

Authors:  Emma N Hilton; Tommy R Lundberg
Journal:  Sports Med       Date:  2021-02       Impact factor: 11.136

Review 5.  Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?

Authors:  Tormod S Nilsen; Sara Hassing Johansen; Lene Thorsen; Ciaran M Fairman; Torbjørn Wisløff; Truls Raastad
Journal:  Int J Environ Res Public Health       Date:  2022-03-23       Impact factor: 3.390

Review 6.  Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.

Authors:  Justin P Hardee; Ryan N Montalvo; James A Carson
Journal:  Oxid Med Cell Longev       Date:  2017-12-11       Impact factor: 6.543

7.  Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.

Authors:  Patrick J Owen; Robin M Daly; Patricia M Livingston; Niamh L Mundell; Jack Dalla Via; Jeremy L Millar; Steve F Fraser
Journal:  Trials       Date:  2017-10-03       Impact factor: 2.279

8.  Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.

Authors:  Jacqueline K Dawson; Tanya B Dorff; E Todd Schroeder; Christianne J Lane; Mitchell E Gross; Christina M Dieli-Conwright
Journal:  BMC Cancer       Date:  2018-04-03       Impact factor: 4.430

Review 9.  Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review.

Authors:  Rebekah L Wilson; Dennis R Taaffe; Robert U Newton; Nicolas H Hart; Philippa Lyons-Wall; Daniel A Galvão
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

10.  Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy.

Authors:  Rebekah L Wilson; Robert U Newton; Dennis R Taaffe; Nicolas H Hart; Philippa Lyons-Wall; Daniel A Galvão
Journal:  Med Sci Sports Exerc       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.